I now have comprehensive material from all three core textbooks plus Guyton. Here is the full MD exam-level answer:
Q175: Factors Controlling Coronary Blood Flow
Introduction
Coronary blood flow (CBF) in the resting adult averages 250 mL/min (~5% of cardiac output) and is one of the most tightly regulated circulations in the body. The myocardium is uniquely oxygen-dependent: it extracts ~70% of delivered oxygen at rest (coronary sinus SvO2 ~30%), compared to ~25% in most other tissues. Therefore, any increase in myocardial oxygen demand (MVO2) must be met almost exclusively by an increase in coronary blood flow - not by increased extraction.
(Morgan & Mikhail, 7e, Chapter 20; Barash Clinical Anesthesia, 9e, Chapter 12)
Coronary Perfusion Pressure (CPP)
CPP is the primary driving force for coronary blood flow.
Left ventricle:
CPP (LV) = Aortic Diastolic Pressure (AoDP) - LV End-Diastolic Pressure (LVEDP)
The LV is perfused almost exclusively during diastole because systolic intramyocardial compression exceeds perfusion pressure during contraction. The subendocardium is most vulnerable to ischemia as it is directly exposed to intracavitary pressures.
Right ventricle:
CPP (RV) = Aortic mean pressure - RV end-diastolic pressure
The RV, having lower wall stress, is perfused in both systole and diastole (unless pulmonary hypertension is present).
Key implications:
- Tachycardia shortens diastolic filling time and reduces LV perfusion time - this is the most important cause of perioperative ischemia
- Raised LVEDP (e.g., volume overload, poor compliance) reduces CPP
- Hypotension reduces AoDP and compromises perfusion
(Barash, 9e, p. 3285)
Autoregulation
The coronary circulation maintains relatively constant blood flow over a wide range of perfusion pressures through pressure-flow autoregulation.
- Autoregulation is effective between perfusion pressures of 50-120 mmHg
- Below 50 mmHg, flow becomes pressure-dependent (autoregulation is lost)
- Autoregulation of subendocardial flow is lost when perfusion pressure falls below 40 mmHg
- Beyond 120 mmHg, forced vasodilation occurs
The mechanism involves myogenic response (vascular smooth muscle contracts in response to stretch) and metabolic adjustment of arteriolar tone.
(Morgan & Mikhail, 7e, p. 683; Barash, 9e, p. 3285)
Metabolic (Local) Regulation - The Primary Controller
This is the dominant mechanism under physiological conditions. The coronary vasculature couples blood flow to metabolic demand through several local vasodilators released from hypoxic/working myocardium:
| Vasodilator | Mechanism |
|---|
| Adenosine | ATP degrades to AMP → adenosine when O2 demand exceeds supply; potent arteriolar dilator |
| Nitric Oxide (NO) | Released by endothelial eNOS in response to shear stress and receptor activation (bradykinin, acetylcholine); activates cGMP → smooth muscle relaxation |
| KATP channels | Open when intracellular ATP falls; hyperpolarize smooth muscle → vasodilation |
| CO2 / H+ | Products of aerobic metabolism; local vasodilators |
| K+ ions | Released with action potentials; vasodilate arterioles |
| Prostaglandins (PGI2) | Prostacyclin; opens KATP channels, weakly vasodilatory |
| Reactive O2 species | "Feed-forward" mediators generated during energy utilization |
Endothelin-1 (ET-1) is a potent vasoconstrictor produced by endothelium; under normal conditions its effect is counterbalanced by tonic NO release. Pathologic states (diabetes, hypertension, heart failure) tip the balance toward vasoconstriction.
(Guyton & Hall, Chapter 21; Barash, 9e, p. 860)
Coronary Vascular Reserve
Coronary vascular reserve (CVR) = difference between autoregulated (basal) flow and maximal vasodilation flow.
- Normal CVR = 3-5 times basal flow (500-600% of baseline for LV and RV)
- CVR is reduced by: epicardial stenosis, pressure-overload hypertrophy, microvascular dysfunction
- Stenosis of 50% luminal diameter = first impairment in reactive hyperemia
- Stenosis of ~90% = abolishes peak hyperemia = unstable angina threshold
As stenosis progresses, arterioles vasodilate progressively to preserve resting flow, but reserve is consumed - leaving the myocardium vulnerable to any further increase in demand.
(Barash, 9e, p. 861)
Autonomic (Neural) Control
Neural control is secondary to metabolic control and is generally overridden by local metabolic mechanisms within seconds.
Sympathetic Nervous System
- Direct effects: Both α1 and β2 receptors present
- α1 receptors: predominantly on larger epicardial vessels → vasoconstriction
- β2 receptors: predominantly on smaller intramuscular/subendocardial vessels → vasodilation
- Indirect effects (dominant): Sympathetic stimulation ↑ HR and contractility → ↑ MVO2 → metabolic vasodilation overwhelms direct vasoconstriction
- Net effect: coronary blood flow increases with sympathetic stimulation due to dominant β2 + metabolic override
- Pathological exception: In some individuals, disproportionate α1 activation causes vasospastic ischemia (variant/Prinzmetal angina)
Parasympathetic Nervous System
- Vagal innervation of ventricular coronary vessels is sparse
- Acetylcholine has a direct, weak vasodilatory effect on coronary arteries
- Indirect effect: Vagal slowing of HR ↓ MVO2 → indirect vasoconstriction
- Net effect: minor and usually clinically insignificant
(Guyton & Hall, p. 269; Morgan & Mikhail, 7e, p. 683)
Humoral / Endocrine Factors
| Factor | Effect on CBF |
|---|
| Epinephrine | β2-mediated vasodilation at low doses; α1 at high doses |
| Angiotensin II | Vasoconstriction (via AT1 receptors) |
| Vasopressin | Vasoconstriction |
| Bradykinin | Vasodilation (via NO release from endothelium) |
| Histamine | Vasodilation (via H2 receptors) |
| Serotonin | Vasoconstriction at high doses; variable |
Physical / Mechanical Factors
Extravascular Compression
During systole, intramyocardial wall tension compresses intramural vessels (especially subendocardial). This is why:
- LV flow is predominantly diastolic
- Tachycardia is particularly harmful - reduces diastolic time disproportionately
Heart Rate
- Increased HR = reduced diastolic perfusion time (supply ↓)
- Increased HR = increased MVO2 (demand ↑)
- This double jeopardy makes tachycardia the most dangerous factor in myocardial ischemia
Ventricular End-Diastolic Pressure
- Elevated LVEDP compresses subendocardial vessels and reduces CPP gradient
- Morgan & Mikhail specifically list LVEDP as both a supply factor (reducing perfusion) and a demand factor (increasing wall stress)
Myocardial Oxygen Supply-Demand Balance (Summary Table)
(From Morgan & Mikhail, 7e, Table 20-7)
| SUPPLY | DEMAND |
|---|
| Heart rate (diastolic filling time) | Heart rate |
| Coronary perfusion pressure | Wall tension (preload + afterload) |
| Aortic diastolic pressure | Preload (ventricular radius) |
| LVEDP | Afterload |
| Arterial O2 content (PaO2, Hb) | Contractility |
| Coronary vessel diameter | Basal metabolic requirements |
Oxygen Consumption Distribution
- Basal requirements: 20%
- Electrical activity: 1%
- Volume work: 15%
- Pressure work: 64%
This explains why pressure work (afterload) is the most important determinant of MVO2 and why hypertension is so dangerous for the ischemic heart.
(Morgan & Mikhail, 7e, p. 683)
Ischemia: Supply vs. Demand
| Type | Mechanism | Example |
|---|
| Supply-induced ischemia | Transient coronary occlusion | Vasospasm, thrombus |
| Demand-induced ischemia | Inability to increase CBF proportional to MVO2 | Fixed stenosis + tachycardia |
| Stunned myocardium | Temporary dysfunction post-ischemia; no cell death | Post-reperfusion |
| Hibernating myocardium | Chronically ↓ flow; downregulated metabolism | Chronic fixed stenosis |
| Irreversible injury | Occlusion >20 minutes → cell death | MI |
(Barash, 9e, pp. 3285-3286)
Anaesthetic Implications
- Volatile agents: Most are coronary vasodilators; net effect on CBF is variable due to simultaneous reduction in MVO2 and blood pressure
- Spinal/epidural to T4: Decreases CBF in proportion to MAP reduction; can improve regional myocardial function in ischemic patients by reducing afterload and MVO2
- High thoracic epidural: Beneficial in ischemic heart disease - reduces sympathetic tone, wall stress, and MVO2
- Tachycardia prevention is the most important intraoperative goal - the single factor that simultaneously reduces supply and increases demand
- Vasopressors: Pure α-agonists (phenylephrine) increase AoDP (supply) but also increase afterload (demand); ephedrine increases HR (harmful); norepinephrine is generally preferred in hypotension with tachycardia
(Miller's Anesthesia, 10e, Chapter on neuraxial anesthesia; Morgan & Mikhail, 7e)
Key Points for MD Exam
- Primary controller = metabolic regulation via adenosine, NO, KATP channels
- Autoregulation range = 50-120 mmHg; subendocardial autoregulation lost at <40 mmHg
- LV perfused in diastole only - tachycardia is the most dangerous hemodynamic change
- CPP (LV) = AoDP - LVEDP; both ends of this equation must be optimized
- Neural control is secondary and overridden by metabolic control within seconds
- Coronary reserve = 3-5x basal flow; stenosis >50% begins to impair reactive hyperemia
- Pressure work accounts for 64% of MVO2 - hypertension is the biggest demand driver
- Endothelium is central - eNOS/NO, endothelin-1 balance; disrupted in atherosclerosis/diabetes
References: Miller's Anesthesia 10e (neuraxial anesthesia chapter); Barash Clinical Anesthesia 9e, Chapter 12 (Coronary Physiology) and Chapter 39 (Coronary Blood Flow); Morgan & Mikhail's Clinical Anesthesiology 7e, Chapter 20; Guyton & Hall Medical Physiology, Chapter 21 (Control of Coronary Blood Flow); Sato T et al. J Cardiol 2024 - innervation of coronary arteries [PMID: 38346669]